// App-Quantinova.ai

: The pathophysiology of essential hypertension in young/middle-age, and treatment implications

Researchers

Presenter

  • John Malcolm Cruickshank

Principal Investigators

  • N/A

Medical Centers

  • Cardiovascular Consultant, London

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Essential arterial hypertension

  • Obesity

Biomarkers

  • Snail Family Transcriptional Repressor 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved